PA
BZ icon

PharVision Advisers’s Kanzhun BZ Stock Holding History

PharVision Advisers’s Portfolio BZ Stock Details BZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,970
Closed -$244K – 176
2025
Q4 		$244K Sell
11,970
-2,473
-17% -$53.4K 0.12% 410
2025
Q3 		$337K Buy
+14,443
New +$310K 0.19% 161

Other funds holding BZ

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCM
CoreView Capital Management Hong Kong $473M AUM 14.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PharVision Advisers's BZ Position: Q1 2026 in Review

PharVision Advisers sold out of Kanzhun (BZ) in Q1 2026, closing a stake of 11,970 shares — an estimated $244K sold.

PharVision Advisers first reported a position in BZ in Q3 2025 and held it in 2 quarters. The position peaked at $337K in Q3 2025. 258 funds tracked by Wall St. Rank hold BZ as of Q1 2026.

  • PharVision Advisers reported no remaining Kanzhun position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 11,970 Kanzhun shares in Q1 2026, an estimated $244K.
  • PharVision Advisers first reported a position in Kanzhun in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Kanzhun position peaked at $337K in Q3 2025.
  • 258 funds tracked by Wall St. Rank held Kanzhun as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.